HIV/AIDS News

BOSTON — Recent data show that, overall, new HIV diagnoses are declining among women in the United States. However, more than 7,000 women were diagnosed with HIV in 2016, and certain populations continue to be disproportionately affected by the epidemic, including black women and white women who inject drugs, according to the CDC.

BOSTON — Each year, HHS and the CDC recognize March 10 as National Women and Girls HIV/AIDS Awareness Day to support women and girls who are living with HIV and ensure that uninfected women have the knowledge and tools they need to prevent infection.

Providing an intervention intended to prevent HIV, STIs, substance use and mental health concerns to youth placed on probation can reduce sexual risk behaviors in juvenile offenders, according to findings published in Health Psychology.

BOSTON — Although HIV infection is still prevalent in Lesotho, the country has reached one part of the Joint United Nations Programme on AIDS 90-90-90 goal, and it is close to reaching another, according to researchers.

BOSTON — Adding raltegravir to standard-of-care ART did not impact the incidence or case fatality of immune reconstitution inflammatory syndrome, or IRIS, in patients with advanced HIV, according to study results presented at CROI.

BOSTON — In the Bernard Field Lecture at CROI, Julie M. Overbaugh, PhD, member of the human biology and public health sciences division and Endowed Chair for Graduate Education at the Fred Hutchinson Cancer Research Center in Seattle, discussed one of the earliest trials ever to address the risk for HIV transmission through breast milk and the numerous “downstream studies” that resulted from it. These studies showed what she called “the power of collaboration to drive science.”

BOSTON — A 1-month antibiotic regimen to prevent active tuberculosis in patients living with HIV was just as effective and caused fewer adverse events than a standard 9-month regimen, according to results of a phase 3 clinical trial presented at CROI.

The global pharmaceutical company Mylan announced today that it will be introducing two new HIV treatment regimens — Symfi Lo and Cimduo — in the United States.

People living with HIV who are diagnosed with cancer should be offered the same treatment as those without HIV; however, considerations should be made for potential interactions and toxicities, according to new practice guidelines from the National Comprehensive Cancer Network.

Adolescents involved in the juvenile justice system demonstrated reduced incidence of sexually transmitted infections after taking part in a one-time sexual risk reduction intervention that incorporates content related to alcohol and cannabis use.